Invenomic Capital Management’s Purple Innovation PRPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$331K Sell
500,000
-125,646
-20% -$87.9K 0.02% 147
2025
Q4
$432K Sell
625,646
-14,218
-2% -$11.3K 0.02% 143
2025
Q3
$598K Sell
639,864
-34,200
-5% -$32K 0.03% 139
2025
Q2
$492K Sell
674,064
-85,889
-11% -$63.3K 0.03% 144
2025
Q1
$577K Sell
759,953
-35,223
-4% -$32.5K 0.03% 170
2024
Q4
$620K Buy
+795,176
New +$720K 0.03% 159

Other funds holding PRPL

Invenomic Capital Management's PRPL Position: Q1 2026 in Review

Invenomic Capital Management reduced its Purple Innovation (PRPL) stake by 20% in Q1 2026, selling an estimated $87.9K and leaving 500,000 shares worth $331K. The position accounts for 0.02% of the portfolio, ranked #147.

Invenomic Capital Management first reported a position in PRPL in Q4 2024 and has held it in 6 quarters since. The position peaked at $620K in Q4 2024. 70 funds tracked by Wall St. Rank hold PRPL as of Q1 2026.

  • Invenomic Capital Management held 500,000 shares of Purple Innovation worth $331K as of Q1 2026.
  • Invenomic Capital Management sold 125,646 Purple Innovation shares in Q1 2026, an estimated $87.9K.
  • Purple Innovation made up 0.02% of Invenomic Capital Management's portfolio in Q1 2026, its #147 holding.
  • Invenomic Capital Management first reported a position in Purple Innovation in Q4 2024 and has held it in 6 quarters since.
  • Invenomic Capital Management's Purple Innovation position peaked at $620K in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Purple Innovation as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.